Rho GTPases: potential candidates for anticancer therapy
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 206 (2) , 181-191
Abstract
No abstract availableKeywords
This publication has 105 references indexed in Scilit:
- Emerging functions of p21‐activated kinases in human cancer cellsJournal of Cellular Physiology, 2002
- Rho Activity Can Alter the Translation of p27 mRNA and Is Important for RasV12-induced Transformation in a Manner Dependent on p27 StatusJournal of Biological Chemistry, 2002
- Distinct Role of Phosphatidylinositol 3-Kinase and Rho Family GTPases in Vav3-induced Cell Transformation, Cell Motility, and Morphological ChangesJournal of Biological Chemistry, 2002
- Cooperativity between the Ras-ERK and Rho-Rho Kinase Pathways in Urokinase-type Plasminogen Activator-stimulated Cell MigrationJournal of Biological Chemistry, 2002
- IQGAP1-mediated Stimulation of Transcriptional Co-activation by β-Catenin Is Modulated by CalmodulinJournal of Biological Chemistry, 2002
- Rho regulates p21CIP1, cyclin D1, and checkpoint control in mammary epithelial cellsOncogene, 2002
- Rac1 Protects Epithelial Cells against AnoikisJournal of Biological Chemistry, 2001
- Rho-Kinase Inhibitor Retards Migration and in Vivo Dissemination of Human Prostate Cancer CellsBiochemical and Biophysical Research Communications, 2000
- Rho-like GTPasesEuropean Journal of Cancer, 1999
- Cdc42, Rac1, and Their Effector IQGAP1 as Molecular Switches for Cadherin-Mediated Cell–Cell AdhesionBiochemical and Biophysical Research Communications, 1999